173 related articles for article (PubMed ID: 17036332)
1. Unbalanced expression of licensing DNA replication factors occurs in a subset of mantle cell lymphomas with genomic instability.
Pinyol M; Salaverria I; Bea S; Fernández V; Colomo L; Campo E; Jares P
Int J Cancer; 2006 Dec; 119(12):2768-74. PubMed ID: 17036332
[TBL] [Abstract][Full Text] [Related]
2. Loss of Geminin induces rereplication in the presence of functional p53.
Melixetian M; Ballabeni A; Masiero L; Gasparini P; Zamponi R; Bartek J; Lukas J; Helin K
J Cell Biol; 2004 May; 165(4):473-82. PubMed ID: 15159417
[TBL] [Abstract][Full Text] [Related]
3. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
[TBL] [Abstract][Full Text] [Related]
4. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
5. Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines.
Xouri G; Lygerou Z; Nishitani H; Pachnis V; Nurse P; Taraviras S
Eur J Biochem; 2004 Aug; 271(16):3368-78. PubMed ID: 15291814
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
7. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
8. Cdt1 and Geminin in cancer: markers or triggers of malignant transformation?
Petropoulou C; Kotantaki P; Karamitros D; Taraviras S
Front Biosci; 2008 May; 13():4485-94. PubMed ID: 18508524
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
10. DNA replication licensing in somatic and germ cells.
Eward KL; Obermann EC; Shreeram S; Loddo M; Fanshawe T; Williams C; Jung HI; Prevost AT; Blow JJ; Stoeber K; Williams GH
J Cell Sci; 2004 Nov; 117(Pt 24):5875-86. PubMed ID: 15522891
[TBL] [Abstract][Full Text] [Related]
11. Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
Kingsbury SR; Loddo M; Fanshawe T; Obermann EC; Prevost AT; Stoeber K; Williams GH
Exp Cell Res; 2005 Sep; 309(1):56-67. PubMed ID: 16005865
[TBL] [Abstract][Full Text] [Related]
12. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CDC6, geminin, and CDT1 in human cells that undergo polyploidization.
Bermejo R; Vilaboa N; Calés C
Mol Biol Cell; 2002 Nov; 13(11):3989-4000. PubMed ID: 12429841
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
[TBL] [Abstract][Full Text] [Related]
15. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
Tort F; Hernàndez S; Beà S; Martínez A; Esteller M; Herman JG; Puig X; Camacho E; Sánchez M; Nayach I; Lopez-Guillermo A; Fernández PL; Colomer D; Hernàndez L; Campo E
Blood; 2002 Dec; 100(13):4602-8. PubMed ID: 12393693
[TBL] [Abstract][Full Text] [Related]
16. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
[TBL] [Abstract][Full Text] [Related]
17. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours.
Wharton SB; Hibberd S; Eward KL; Crimmins D; Jellinek DA; Levy D; Stoeber K; Williams GH
Br J Cancer; 2004 Jul; 91(2):262-9. PubMed ID: 15199392
[TBL] [Abstract][Full Text] [Related]
18. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
[TBL] [Abstract][Full Text] [Related]
19. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells.
Sugimoto N; Yoshida K; Tatsumi Y; Yugawa T; Narisawa-Saito M; Waga S; Kiyono T; Fujita M
J Cell Sci; 2009 Apr; 122(Pt 8):1184-91. PubMed ID: 19339550
[TBL] [Abstract][Full Text] [Related]
20. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
Rosenwald A; Wright G; Wiestner A; Chan WC; Connors JM; Campo E; Gascoyne RD; Grogan TM; Muller-Hermelink HK; Smeland EB; Chiorazzi M; Giltnane JM; Hurt EM; Zhao H; Averett L; Henrickson S; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Montserrat E; Bosch F; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Fisher RI; Miller TP; LeBlanc M; Ott G; Kvaloy S; Holte H; Delabie J; Staudt LM
Cancer Cell; 2003 Feb; 3(2):185-97. PubMed ID: 12620412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]